Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 229,296 | 96,072 | 126,150 | 76,086 | 104,476 |
| Depreciation Amortization | 82,737 | 78,171 | 64,463 | 60,036 | 42,764 |
| Income taxes - deferred | 13,130 | -13,582 | -46,716 | -3,433 | -2,624 |
| Accounts receivable | 6,556 | -15,000 | -2,700 | -19,686 | -22,981 |
| Accounts payable and accrued liabilities | 10,343 | 6,101 | 5,026 | 5,695 | 8,924 |
| Other Working Capital | -5,246 | -27,751 | 1,896 | -15,451 | -15,041 |
| Other Operating Activity | -131,599 | 57,608 | 22,248 | 40,474 | 28,639 |
| Operating Cash Flow | $205,217 | $181,619 | $170,367 | $143,721 | $144,157 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 76,933 | -21,896 | 27,819 | 3,010 | 776 |
| PPE Investments | -51,744 | -25,411 | -20,934 | -15,179 | -16,898 |
| Net Acquisitions | N/A | -289,492 | -67,851 | -253,785 | -91,423 |
| Purchase Of Investment | 1,906 | N/A | 21,574 | -40,000 | N/A |
| Other Investing Activity | 0 | 0 | 680 | 0 | -25 |
| Investing Cash Flow | $27,095 | $-336,799 | $-38,712 | $-305,954 | $-107,570 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 40,000 | 580,000 | 55,000 | 368,500 | 77,000 |
| Common Stock Issued | 70,983 | 37,950 | 19,170 | 5,257 | 5,458 |
| Common Stock Repurchased | -50,112 | -15,405 | N/A | N/A | N/A |
| Dividend Paid | -48,902 | -48,364 | -47,973 | -47,325 | -47,607 |
| Other Financing Activity | -195,771 | -419,797 | -125,385 | -137,319 | -58,221 |
| Financing Cash Flow | $-183,802 | $134,384 | $-99,188 | $189,113 | $-23,370 |
| Exchange Rate Effect | -2,771 | -308 | -2,089 | 495 | -3,512 |
| Beginning Cash Position | 100,886 | 121,990 | 91,612 | 64,237 | 54,532 |
| End Cash Position | 146,625 | 100,886 | 121,990 | 91,612 | 64,237 |
| Net Cash Flow | $45,739 | $-21,104 | $30,378 | $27,375 | $9,705 |
| Free Cash Flow | |||||
| Operating Cash Flow | 205,217 | 181,619 | 170,367 | 143,721 | 144,157 |
| Capital Expenditure | -51,744 | -25,411 | -20,934 | -15,179 | -16,898 |
| Free Cash Flow | 153,473 | 156,208 | 149,433 | 128,542 | 127,259 |